ProCE Banner Activity

CE

Treatment Guidelines and Pharmacotherapy Options

Multimedia
In this microlearning module, an expert faculty summarizes obesity guideline recommendations, including lifestyle modifications and pharmacotherapy options.

Pharmacists : 0.50 contact {hour} ({0.05} CEUs)

Released: April 08, 2022

Expiration: April 07, 2023

No longer available for credit.

Share

Faculty

Megan Adelman

Megan Adelman, PharmD, BCPS, BCGP, CDCES

Clinical Pharmacist - Family Medicine
Center for Family Medicine
Cleveland Clinic Akron General
Akron, Ohio

Elizabeth Pogge

Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA

Professor 
Department of Pharmacy Practice
College of Pharmacy-Glendale
Midwestern University
Glendale, Arizona

Provided by

Provided by ProCE, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk Inc

Target Audience

The target audience for this program is pharmacists, including clinical, community, specialty, and managed care pharmacists who care for patients with obesity, as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Summarize treatment guidelines, lifestyle modifications, and evidence-based pharmacotherapy options for the management of obesity

Disclosure

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Megan Adelman, PharmD, BCPS, BCGP, CDCES

Clinical Pharmacist - Family Medicine
Center for Family Medicine
Cleveland Clinic Akron General
Akron, Ohio

Megan Adelman, PharmD, BCPS, BCGP, CDCES, has no relevant conflicts of interest to report.

Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA

Professor 
Department of Pharmacy Practice
College of Pharmacy-Glendale
Midwestern University
Glendale, Arizona

Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, has no relevant conflicts of interest to report.

Staff Disclosure

Staff

Robin Black, PharmD, BCACP

Scientific Director

Robin Black, PharmD, BCACP, has no relevant conflicts of interest to report.

Ruth Cohen,

Ruth Cohen Cooper, CHCP, has no relevant conflicts of interest to report.

Instructions for Credit

Continuing Pharmacy Education

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-041-H01-P has been assigned to this home study, knowledge-based activity. This activity is approved for 0.5 contact hour (0.05 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 100% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Disclosure of Unlabeled Use

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 08, 2022, through April 07, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Additional Information

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 08, 2022, through April 07, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve the knowledge and competence of pharmacists regarding obesity management, with an emphasis on the safe use, dosing, titration, and administration of injectable obesity treatment options.